Topamax is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Advanced Rx Pharmacy Of Tennessee, Llc. The primary component is Topiramate.
| Product ID | 80425-0092_b44021d1-33d4-5e6e-e053-2995a90aa07c |
| NDC | 80425-0092 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Topamax |
| Generic Name | Topiramate 50mg |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2009-03-27 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA078235 |
| Labeler Name | Advanced Rx Pharmacy of Tennessee, LLC |
| Substance Name | TOPIRAMATE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2009-03-27 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 21695-128 | Topamax | topiramate |
| 21695-129 | Topamax | topiramate |
| 21695-130 | Topamax | topiramate |
| 50458-639 | Topamax | topiramate |
| 50458-640 | Topamax | topiramate |
| 50458-641 | Topamax | topiramate |
| 50458-642 | Topamax | topiramate |
| 50458-645 | Topamax | topiramate |
| 50458-647 | Topamax | topiramate |
| 55289-433 | Topamax | topiramate |
| 70518-1393 | Topamax | Topamax |
| 61919-189 | TOPAMAX | TOPAMAX |
| 70518-2165 | Topamax | Topamax |
| 70518-2753 | Topamax | Topamax |
| 80425-0092 | Topamax | Topamax |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TOPAMAX 85391764 4128458 Live/Registered |
JOHNSON & JOHNSON 2011-08-08 |
![]() TOPAMAX 78278329 2968496 Dead/Cancelled |
Johnson & Johnson 2003-07-24 |
![]() TOPAMAX 74384910 1909122 Live/Registered |
JOHNSON & JOHNSON 1993-04-23 |